Galderma Investigational Site 8279

New York, New York 10075-0337

1 studies enrolling now · 4 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults — Recruiting now
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed
• Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris — Completed